Showing results (71-80 of 90) with videos related to
Sort By:
Pageof 9
Cancer Research|November 1, 2008
Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent mannerAdam W Studebaker, Gianluca Storci, Jillian L Werbeck, et al.Cells|September 23, 2015
NAD⁺-Metabolizing Ectoenzymes in Remodeling Tumor-Host Interactions: The Human Myeloma ModelAlberto L Horenstein, Antonella Chillemi, Valeria Quarona, et al.BMC Bioinformatics|March 8, 2020
CNV Radar: an improved method for somatic copy number alteration characterization in oncologyDavid Soong, Jeran Stratford, Herve Avet-Loiseau, et al.Blood|May 26, 2016
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myelomaJakub Krejcik, Tineke Casneuf, Inger S Nijhof, et al.JCO Oncology Practice|January 6, 2021
Recommendations to Streamline and Standardize Clinical Trial Site Feasibility Assessments: An ASCO Research StatementDax Kurbegov, Patricia Hurley, David M Waterhouse, et al.Blood Advances|January 4, 2018
Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myelomaTineke Casneuf, Xu Steven Xu, Homer C Adams, et al.Journal of Affective Disorders|November 25, 2020
How are you sleeping? Starting the conversation with fathers about their mental health in the early parenting yearsJacqui A Macdonald, Liam G Graeme, Karen Wynter, et al.Clinical Chemistry and Laboratory Medicine|March 31, 2016
Monitoring multiple myeloma patients treated with daratumumab: teasing out monoclonal antibody interferenceChristopher McCudden, Amy E Axel, Dominique Slaets, et al.Life Science Alliance|October 22, 2022
Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor modelsKristel Kemper, Ellis Gielen, Peter Boross, et al.Blood|May 25, 2016
Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myelomaSaad Z Usmani, Brendan M Weiss, Torben Plesner, et al.Pageof 9